by Carissa Andrews • December 17, 2018
Drugs used in pediatric care can have a long delay from the time the medication is originally approved—to the time trials are completed for use with children. An audit done by Boston’s Children’s Hospital found only one-third of mandatory trials on children’s efficacy and usage were completed in a seven-year timespan after a new drug hits the market. This can often leave a gaping hole in treatment areas—or worse yet, leave a doctor or pharmacist left to guess at whether or not it can safely treat kids.
Drug Safety
,
Parenting Board
,
Tips for Seniors